Some patients achieve their goals on lower doses like 5 milligrams and can remain stable there long-term without further increases
Achievement of T2DM remission following BS is multi-factorial but largely driven by weight loss-related improvements in insulin sensitivity and -cell function, and there are also documented changes in gut physiology, bile acid metabolism, and gut microbiota that appear to have benefits on glycemia [218]
Clinics should have sedation-trained staff on-site during non-anesthetic infusions, as required by Utah law
Sometimes patients assume these symptoms are caused entirely by the medication itself, when nutrition may actually be playing a major role
Escalating before day 14 stacks new nausea on top of resolving nausea, which is the primary driver of discontinuation
Long-term unsupervised use is discouraged